U.S. Alzheimer's Disease Medication Market

U.S. Alzheimer's Disease Medication Market published by Frost & Sullivan in August, 2010. This report consists of 94 pages and the price starts from US $ 6000.

Introduction

This research service provides an indepth analysis of factors affecting the growth of the U.S. Alzheimer' s disease medication market over the period 2006-2016. Following an introduction to the market, which includes segmentation, patient forecasts, and market trends, readers are presented with a detailed examination of therapeutic candidates in Alzheimer' s pipeline. Finally, revenue forecasts and market share analyses are presented for existing therapies as well as three new-mechanism drugs with potential to reach the market within the forecast period.

1. Executive Summary

U.S. Alzheimer' s Disease Medication Market

• Introduction

2. Market Introduction

Research Scope and Methodology

• Scope and Segmentation
• Research Methodology

Disease Overview and Patient Forecasts

• Disease Overview
• Diseases Causes and Risk Factors
• Diagnosis
• Patient Forecasts

Market Trends

• Market Engineering Measurements
• Industry Challenges and Strategies
• Market Drivers

3. Product and Pipeline Analysis

Approved Product Overview

• Introduction
• Cholinesterase Inhibitors
• NMDA Receptor Antagonists

Pipeline Analysis by Mechanism of Action

• Cholinesterase Inhibitors
• NMDA Receptor Antagonists
• Amyloid Plaque Inhibitors
• Nicotinic Receptor Agonists
• Other New Mechanism Drugs

4. Market Analysis

Revenue Forecasts

• Total Alzheimer' s Disease Medication Market
• Cholinesterase Inhibitors
• NMDA Receptor Antagonists
• Potential New Market Entrants

Competitive Overview

• Competitive Structure

Market Share Analysis

• Market Share Analysis

5. Appendix

Decision Support Databases

• Total Population
• Population Above 65 Years
• Percent of Population Above 65 Years
• Alzheimer' s Disease Population
• Alzheimer' s Disease Deaths
• Total Cases of Dementia

Related Reports